Research progress on moxibustion for relieving chemotherapy-induced adverse drug reactions in cancer patients (艾灸缓解肿瘤化疗相关不良反应的研究进展) by YA Liu (严柳), GAO Yaqian (高雅倩)

Subjects: “…malignant tumor…”
Get full text

Durable disease regression with copanlisib treatment in PI3K-mutated metastasizing ameloblastoma: A case report by Meghan M Lynch, Pedro Hermida-Viveiros, Sean Stencel, Hannah Knott, Rusul Al-Maryati, Farres Obeidin, Borislav A Alexiev, Susan Abbinanti, Senthil Damodaran, Mark Agulnik, Seth M Pollack

“…Rare Tumors…”
Get full text

Diagnosis and management of benign secreting pancreatic insulinoma: What’s new? 4 case report by Khawla Bahou, Youssef Achour, Mehdi Ilahiane, Hamza Sekkat, Younes Bakali, Mouna Mhamdi Alaoui, Mohammed Raiss, Farid Sabbah, Abdelmalek Hrora

“…Rare Tumors…”
Get full text

Herbal based nanoparticles as a possible and potential treatment of cancer: a review by Roshan Yadav, Himmat Singh Chawra, Gaurav Dubey, Md Sabir Alam, Vikram Kumar, Pragya Sharma, Navneet Kumar Upadhayay, Tejpal Yadav

“…Exploration of Targeted Anti-tumor Therapy…”
Get full text

Implications of noncoding RNAs for cancer therapy: Are we aiming at the right targets? by Amil Shah

“…Exploration of Targeted Anti-tumor Therapy…”
Get full text

Assessment of lipid peroxidation and total antioxidant capacity in patients with breast cancer by Abdullatif Taha Babakr, Mohamed Mahmoud Nour Eldein

“…Exploration of Targeted Anti-tumor Therapy…”
Get full text

Neoantigen immunotherapy: a novel treatment for bladder cancer by Ruiyang Lv, Zhenzhu Liu, Maoxin Lv, Yuze Song, Junlin Wang, Huizhi Mu, Yu Zhang, Xuejian Wang

“…Exploration of Targeted Anti-tumor Therapy…”
Get full text

Concomitant exposure to benzodiazepines during pembrolizumab-based therapy for advanced non-small-cell lung cancer: a propensity-score matched analysis of monitoring agency data by Fabrizio Nelli, Enzo Maria Ruggeri, Antonella Virtuoso, Diana Giannarelli, Armando Raso, Federica Natoni, Gloria Pessina, Daniele Remotti, Mario Giovanni Chilelli, Carlo Signorelli, Agnese Fabbri

“…Exploration of Targeted Anti-tumor Therapy…”
Get full text

[18F]-(2S,4R)4-Fluoroglutamine PET Imaging of Glutamine Metabolism in Murine Models of Hepatocellular Carcinoma (HCC) by Youngho Seo, Miranda C. Craig, Stephanie T. Murphy, Jinjin Feng, Xin Chen, Mariia Yuneva

“…Influx rate constants were significantly higher for MYC tumors (K1=0.374±0.133) than for MET tumors (K1=0.141±0.058) under fasting conditions (P=0.0002). …”
Get full text

Histopathological Study of Skin Adnexal Tumours—Institutional Study in South India by Ankit Sharma, Deepak G. Paricharak, Jitendra Singh Nigam, Shivani Rewri, Priyanka Bhatia Soni, Anita Omhare, Preethi Sekar

“…Results. 80.36% (45/56) were benign and 19.64% (11/56) were malignant adnexal tumors. The sweat gland tumors constituted the largest group (42.86% 24/56) cases followed by the hair follicle tumors (35.71%, 20/56) of cases and sebaceous gland tumors (21.43%, 12/56) cases. …”
Get full text

Molecular Markers in Upper Urothelial Carcinoma Associated to Balkan Endemic Nephropathy. Aristolochic Acid as the Major Risk Factor of the Worldwide Disease by Ljubinka Jankovic Velickovic, Takanori Hattori, Vladisav Stefanovic

“…BEN low-stage tumors, tumors without limphovascular invasion (LVI), and tumors of the renal pelvis had a higher p53 index than the control tumors (p < 0.05, 0.01, 0.05, respectively). …”
Get full text

TERTp Mutation and its Prognostic Value in Glioma Patients Under the 2021 WHO Classification: A Real‐World Study by Hao Xing, Delin Liu, Junlin Li, Yulu Ge, Xiaopeng Guo, Wenlin Chen, Dachun Zhao, Yixin Shi, Yilin Li, Yaning Wang, Yuekun Wang, Yu Xia, Jiaming Wu, Tingyu Liang, Hai Wang, Qianshu Liu, Shanmu Jin, Tian Qu, Siying Guo, Huanzhang Li, Tianrui Yang, Kun Zhang, Yu Wang, Wenbin Ma

“…ABSTRACT Background The 2021 WHO Classification of Central Nervous System Tumors introduces more molecular markers for glioma reclassification, including TERT promoter (TERTp) mutation as a key feature in glioblastoma diagnosis. …”
Get full text

Association between transcription factors expression and growth patterns of nonfunctioning pituitary adenomas by Jiakun Xu, Shaolin Zhang, Weijie Su, Jia Yang, Lixuan Yang, Xixi Li

“…Isolated infrasellar extension is specific to TPIT tumors and can serve as a radiologic sign to distinguish between TPIT tumors and SF-1 tumors.…”
Get full text

Giant ovarian serous cystadenoma. A case report by Jorge Luis Estepa Pérez, Tahiluma Santana Pedrasa, Daniel Olivera Fajardo

“…Ovarian tumors are not as common as uterus and breast tumors. …”
Get full text

Dysbiosis and extraintestinal cancers by Ruishan He, Pingqian Qi, Linzhen Shu, Yidan Ding, Peng Zeng, Guosheng Wen, Ying Xiong, Huan Deng

“…Additionally, we delve into the limitations inherent in current methodologies, particularly the challenges associated with differentiating low loads gut-derived microbiome within tumors from potential sample contamination or symbiotic microorganisms. …”
Get full text

Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma by Daniel Oyon, Amaya Lopez-Pascual, Borja Castello-Uribe, Iker Uriarte, Giulia Orsi, Sofia Llorente, Jasmin Elurbide, Elena Adan-Villaescusa, Emiliana Valbuena-Goiricelaya, Ainara Irigaray-Miramon, Maria Ujue Latasa, Luz A. Martinez-Perez, Luca Reggiani Bonetti, Felipe Prosper, Mariano Ponz-Sarvise, Silvestre Vicent, Antonio Pineda-Lucena, David Ruiz-Clavijo, Bruno Sangro, Urko Aguirre Larracoechea, Tian V. Tian, Andrea Casadei-Gardini, Irene Amat, Maria Arechederra, Carmen Berasain, Jesus M. Urman, Matias A. Avila, Maite G. Fernandez-Barrena

“…CM272 also enhanced chemotherapy sensitivity and significantly inhibited tumor growth in vivo without detectable toxicity. …”
Get full text

Octreotide in the treatment of neuroendocrine carcinomas: Is the success achieved? by L. Yu. Morgunov

“…Diagnosis and treatment of functioning and non-functioning neuroendocrine tumors is a challenging task. Surgeru remains the only radical method of treatment of these tumors, but tumors often are diagnosed at the stage of metastasis, when only palliative treatment is possible. …”
Get full text

Metformin in the treatment of colorectal cancer and neuroendocrine tumours by Karolina Daniłowska, Natalia Picheta, Barbara I. Krupska, Anna Rudzińska, Oliwia Burdan, Katarzyna Szklener

“…Neuroendocrine tumors most commonly occur in the gastrointestinal tract and lungs. …”
Get full text

Liver cancer multiomics reveals diverse protein kinase A disruptions convergently produce fibrolamellar hepatocellular carcinoma by David Requena, Jack A. Medico, Luis F. Soto-Ugaldi, Mahsa Shirani, James A. Saltsman, Michael S. Torbenson, Philip Coffino, Sanford M. Simon

“…Additionally, we study FLC metastases, finding small differences from the primary tumors.…”
Get full text

Optimal Treatment for Intermediate- and High-Risk, Nonmuscle-Invasive Bladder Cancer by A.P.M. van der Meijden

“…According to clinical and pathological factors the prognosis of a patient with non-muscle invasive bladder tumors can be assessed. The prognosis is determined by the likelihood of recurrence(30-70%) and/or progression to muscle invasive bladder cancer(1-15%).Trans urethral resection of bladder tumors remains the initial therapy but adjuvant intravesical instillations are necessary.All patients benefit from a single immediate post operative instillation with a chemotherapeutic agent and for low risk tumors this is the optimal therapy.Patients with intermediate and high risk tumors need more intravesical chemo-or immunotherapy. …”
Get full text